The content in this preview is based on the last saved version of your email - any changes made to your email that have not been saved will not be shown in this preview.

View this email in your browser

r13-10-6_7-webinar-register.png

JOIN US!


The MRCT Center is delighted to announce a 5 part virtual conference series to advance the design, review, oversight, and conduct of global pediatric clinical trials. Ensuring all children have access to safe and effective medicines is contingent upon the conduct of trials that include them. For many pediatric conditions, disease incidence is low and the pool of potential participants small; conducting multisite and multinational pediatric studies is necessary to secure sufficient enrollment for completion. Given the dearth of relevant data and the challenges of working across jurisdictions, harmonized approaches for pediatric research are necessary.


To ensure wide global relevance and participation, each conference will be offered twice to better accommodate individuals across international time zones, each with the same general agenda but different speakers to hear a variety of opinions.


The first conference in the series will be a three-hour webinar that will focus on applying lessons learned—those sustained and those abandoned– during the COVID-19 pandemic to future work with children in clinical trials:


Advancing International Pediatric Clinical Research

PART ONE: INFORMING THE FUTURE FROM COVID-19 LESSONS LEARNED

OCTOBER 6, 2021 from 6:00 PM - 9:00 PM EDT

OCTOBER 7, 2021 from 8:00 AM - 11:00 AM EDT


You may register for one or both! We are delighted to announce the keynote speakers:


October 6, 2021: REGISTER NOW 

Keynote Speaker:

Dr. Peter Marks

Director, Center for Biologics

Evaluation and Research (CBER),

U.S. Food and Drug Administration (FDA)

USA

October 7, 2021: REGISTER NOW  

Keynote Speaker:

Prof. Mojisola Christianah Adeyeye

Director, General of The National Agency for Food and Drug Administration and Control (NAFDAC)

Nigeria

Each keynote speaker will be followed by two moderated panel discussions to:

  1. Deliberate the appropriateness and timing of initiating trials in children, and the different age groups within the broad scope of “children,” using lessons learned from COVID-19 and applying that learning to future pediatric trials.
  2. Address infrastructure, both new and adaptations to existing structures, needed to conduct efficient and ethical pediatric clinical trials on a global scale.


This series is supported by an FDA Scientific Conference Grant.

Please visit the MRCT Center R13 Webinar series page for up-to-date information.

REGISTER NOW

Follow us for updates!

Twitter  LinkedIn

Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

14 Story Street, 4th Floor, Cambridge, MA 02138

MRCTCenter.org